Vitamin B-17

•*¨*•.¸¸¸¸.•*¨*••*¨*Infuse some LOVE Energy into

someone that needs a boost.

They won't forget it...

in fact, they will pass it on

                                        to another! •*¨*•.¸¸¸¸.•*¨*••*¨*

Laetrile is natural and powerful anti-tumor agent found in over 1,200 plants, and is best known for its ability to prevent metastases without collateral damage to healthy normal cells.

Vitamin B-17

Laetrile is particularly concentrated in the stones and seeds of common fruits such as apricots, peaches, plums and apples. It is a diglucoside with a cyanide radical that is highly "bio-accessible", i.e., able to penetrate through the cellular membrane to reaching high intra-cellular concentrations.

Laetrile serves as glucose to healthy cells that provide energy when metabolized. Normal healthy cells contain an enzyme called rhodenase, which "neutralizes" the laetrile by preventing it from releasing cyanide. Malignant cells do not contain the rhodenase enzyme; in the absence of rhodenase, cyanide radical is released within malignant cells when laetrile is activated, resulting in tumor destruction.

Laetrile has been scientifically demonstrated to be non-toxic; our own experience with thousands of patients gives us complete confidence that this natural agent poses no danger in treatment.

Cancer cells contain thousands of times more of the enzyme beta-glucosidase than noncancerous cells.

When Laetrile interacts with beta-glucosidase, it breaks down into its component structures:

• Two molecules of glucose, a sugar

• One molecule of benzaldehyde, an analgesic (pain-relieving drug)

• One molecule of hydrocyanic acid, a poison

The pharmacological equation might be expressed like this: beta-glucosidase + laetrile = toxic cyanide that is naturally targeted/isolated to cancerous cells. Additionally, the Laetrile/beta-glucosidase reaction triggers the release of the Benzaldehyde, a known analgesic.

Laetrile is effective in reducing tumor related pain and increasing the survivability of late stage critical patients. It is best known for its ability to prevent metastases in all types of cancers.

As early as 1974, Laetrile was being used intravenously at levels of six to nine thousand milligrams daily (i.e. six to nine grams). In general, an accumulation of fifty to seventy grams of Laetrile over a period of seven to ten days is needed before patients experience tangible improvement.

Through treatment of thousands of patients,  Functional Oncology team has identified found the most impactful method of Laetrile treatment is six grams, intravenously delivered once per day over a period of three weeks. Although Laetrile can be administered orally, the not uncommon presence of intestinal bacteria can result in small amounts of cyanide production, necessitating that oral doses be limited to three grams or less per day (and therefore a longer program of accumulating treatment effect).